基本信息
views: 0
Career Trajectory
Bio
Research into the immunobiology of allogeneic hematopoietic cell transplantation and adoptive cell therapies may be instrumental in developing effective cancer treatments. Our laboratory’s program of research has as its goal the elucidation and therapeutic exploitation of the biology of cell-based adoptive immunotherapies used in conjunction with allogeneic hematopoietic cell transplants. These transplants are designed to confer enhanced tumor resistance to patients transplanted for hematopoietic malignancies and to promote reconstitution of immunity to viral pathogens in the post transplant period.
Research Interests
Papers共 509 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kris Michael Mahadeo,Robert Baiocchi,Amer Beitinjaneh,Sridhar Chaganti, Sylvain Choquet,Daan Dierickx,Rajani Dinavahi, Xinyuan Duan,Laurence Gamelin,Armin Ghobadi,Norma Guzman-Becerra,Manher Joshi,
LANCET ONCOLOGYno. 3 (2024): 376-387
Cited0Views0Bibtex
0
0
Kris Michael Mahadeo,Robert Baiocchi,Amer Beitinjaneh,Sridhar Chaganti, Sylvain Choquet,Daan Dierickx,Rajani Dinavahi, Xinyuan Duan,Laurence Gamelin,Armin Ghobadi,Norma Guzman-Becerra,Manher Joshi,
The Lancet. Oncologyno. 3 (2024): 376-387
BONE MARROW TRANSPLANTATIONno. 1 (2024): 23-33
FRONTIERS IN IMMUNOLOGY (2024): 1290059-1290059
Cytotherapyno. 4 (2024): 351-359
Journal for ImmunoTherapy of Cancerno. 9 (2023): e006889-e006889
crossref(2023)
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn